In biotech, these news-to-price swings often reflect sentiment, not fundamentals. Until data or partnerships land, $NVAX likely trades like a bellwether.
Not adding here; news cycle feels like noise.
Is this just a liquidity squeeze, or is demand actually fading? How much of the $8 level is support versus a new range?
Kinda wild how fast sentiment flips on micro caps. I’m excited, but also nervous—every pop feels like a trap. If this stalls, I’ll feel disappointed; if it tanks, I’ll feel whiplash. Just trying to stay calm.
16% short interest suggests manageable squeeze risk.
Momentum traders are gonna hate this: a 3% fade on UVIX looks like capitulation, but it’s probably just a lagging indicator. If VIX futures keep rolling and IV spikes, I’m leaning long UVXY into the next leg.
For long-term holders, does a 3% dip in UVIX change the risk/reward of hedging with SPY or VIXY, or is this just noise?
From a portfolio view, a 3% drop in UVIX doesn’t change my 1% tail-risk sleeve, but I’m watching VIXY spreads and rolling costs before adjusting.
